| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PALATIN TECHNOLOGIES INC | Director | Common Stock | 36,080 | $76,389 | $2.12 | 15 Jul 2024 | Direct |
| PALATIN TECHNOLOGIES INC | Director | Stock Option (Right to Buy) | 54,280 | 15 Jul 2023 | Direct | ||
| Monte Rosa Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 30,700 | 13 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | 13 Jun 2025 | 1 | $0 | 4 | Director | 16 Jun 2025, 16:05 |
| PTN | PALATIN TECHNOLOGIES INC | 15 Jul 2024 | 2 | $0 | 4 | Director | 16 Jul 2024, 16:31 |
| GLUE | Monte Rosa Therapeutics, Inc. | 12 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 16:30 |
| GLUE | Monte Rosa Therapeutics, Inc. | 25 Jul 2023 | 1 | $0 | 4 | Director | 26 Jul 2023, 16:10 |
| GLUE | Monte Rosa Therapeutics, Inc. | 25 Jul 2023 | 0 | $0 | 3 | Director | 26 Jul 2023, 16:05 |
| PTN | PALATIN TECHNOLOGIES INC | 20 Jun 2023 | 2 | $0 | 4 | Director | 22 Jun 2023, 17:00 |
| PTN | PALATIN TECHNOLOGIES INC | 22 Jun 2022 | 2 | $0 | 4 | Director | 24 Jun 2022, 19:31 |
| PTN | PALATIN TECHNOLOGIES INC | 22 Jun 2021 | 2 | $0 | 4 | Director | 24 Jun 2021, 17:01 |